AFFOMIX, INC.

Basic Information

AFFOMIX, INC.
52 LEIGHTON TRAIL
GUILFORD, CT, 06437

Company Profile

n/a

Additional Details

Field Value
DUNS: 623623803
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of a method to multiplex ChIP-SEQ and ChIP-chip experiments

    Amount: $96,738.00

    DESCRIPTION (provided by applicant): The immediate objective of our research is to generate a method that will enable researchers to multiplex Chromatin ImmunoPreciptation-Sequencing (ChIP-Seq) analys ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. High-throughput screening and identification of scFv antibodies against glycosyla

    Amount: $193,520.00

    DESCRIPTION (provided by applicant): The specific goal of this proposal is to develop a high-throughput method to identify scFv antibodies that recognize post-translationally modified proteins. We pro ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. A bifunctional antibody screening system for both phage display and yeast two-hyb

    Amount: $200,035.00

    DESCRIPTION (provided by applicant): This is a proposal to establish a proof-of-principle for a vector system to isolate high-affinty antibodies through selective rounds in both yeast and Escherichia ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. Emulsion phage display for high-throughput isolation of affinity binders

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): We propose to develop an inexpensive high-throughput means of selecting and identifying antibodies to both unmodified and modified protein, peptide, and non-pepti ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. HT-production of Abs using Interaction Trap in Yeast

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Affomix would like to commercialize antibody chips to enable researchers to study the human proteome. Currently, researchers use gene chips as a surrogate means ...

    STTR Phase I 2008 Department of Health and Human Services
  6. Microfluidic selection of monoclonal antibodies

    Amount: $111,350.00

    DESCRIPTION (provided by applicant): Nearly 20 years ago, partially as a response to leveraging the genomics research the NIH invested in the development of gene array technologies. These gene chips' ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government